|
1
|
Mozaffarian Go AS, Roger D, Benjamin VL,
Berry EJ, Blaha JD, Dai MJ, Ford S, Fox ES, Franco CSS, et al:
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee: Executive summary: heart disease and
stroke statistics - 2014 update: a report from the American Heart
Association. Circulation. 129:399–410. 2014. View Article : Google Scholar
|
|
2
|
Kelly BB, Narula J and Fuster V:
Recognizing global burden of cardiovascular disease and related
chronic diseases. Mt Sinai J Med. 79:632–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muka T, Imo D, Jaspers L, Colpani V,
Chaker L, van der Lee SJ, Mendis S, Chowdhury R, Bramer WM, Falla
A, et al: The global impact of non-communicable diseases on
healthcare spending and national income: A systematic review. Eur J
Epidemiol. 30:251–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guilherme A, Virbasius JV, Puri V and
Czech MP: Adipocyte dysfunctions linking obesity to insulin
resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 9:367–377.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu H, Barnes GT, Yang Q, Tan G, Yang D,
Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, et al: Chronic
inflammation in fat plays a crucial role in the development of
obesity-related insulin resistance. J Clin Invest. 112:1821–1830.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ng M, Fleming T, Robinson M, Thomson B,
Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF,
et al: Global, regional, and national prevalence of overweight and
obesity in children and adults during 1980–2013: A systematic
analysis for the Global Burden of Disease Study 2013. Lancet.
384:766–781. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Whitman SC: A practical approach to using
mice in atherosclerosis research. Clin Biochem Rev. 25:81–93.
2004.
|
|
8
|
Cannon CP, Harrington RA, James S,
Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M,
Khurmi NS, et al: PLATelet inhibition and patient outcomes
investigators: Comparison of ticagrelor with clopidogrel in
patients with a planned invasive strategy for acute coronary
syndromes (PLATO): A randomised double-blind study. Lancet.
375:283–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meier P and Timmis A: Almanac 2012:
interventional cardiology: the national society journals present
selected research that has driven recent advances in clinical
cardiology. Heart. 98:1701–1709. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gómez-Gaviro MV, Lovell-Badge R,
Fernández-Avilés F and Lara-Pezzi E: The vascular stem cell niche.
J Cardiovasc Transl Res. 5:618–630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Klein D, Weisshardt P, Kleff V, Jastrow H,
Jakob HG and Ergün S: Vascular wall-resident CD44+
multipotent stem cells give rise to pericytes and smooth muscle
cells and contribute to new vessel maturation. PLoS One.
6:e205402011. View Article : Google Scholar
|
|
12
|
Zengin E, Chalajour F, Gehling UM, Ito WD,
Treede H, Lauke H, Weil J, Reichenspurner H, Kilic N and Ergün S:
Vascular wall resident progenitor cells: A source for postnatal
vasculogenesis. Development. 133:1543–1551. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Caplan AI: Mesenchymal stem cells. Stem
Cells Transl Med. 6:1445–1451. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krampera M, Glennie S, Dyson J, Scott D,
Laylor R, Simpson E and Dazzi F: Bone marrow mesenchymal stem cells
inhibit the response of naive and memory antigen-specific T cells
to their cognate peptide. Blood. 101:3722–3729. 2003. View Article : Google Scholar
|
|
15
|
Caplan AI: Adult mesenchymal stem cells
for tissue engineering versus regenerative medicine. J Cell
Physiol. 213:341–347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kode JA, Mukherjee S, Joglekar MV and
Hardikar AA: Mesenchymal stem cells: Immunobiology and role in
immunomodulation and tissue regeneration. Cytotherapy. 11:377–391.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prockop DJ, Brenner M, Fibbe WE, Horwitz
E, Le Blanc K, Phinney DG, Simmons PJ, Sensebe L and Keating A:
Defining the risks of mesenchymal stromal cell therapy.
Cytotherapy. 12:576–578. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tolar J, Le Blanc K, Keating A and Blazar
BR: Concise review: Hitting the right spot with mesenchymal stromal
cells. Stem Cells. 28:1446–1455. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mirza A, Hyvelin JM, Rochefort GY,
Lermusiaux P, Antier D, Awede B, Bonnet P, Domenech J and Eder V:
Undifferentiated mesenchymal stem cells seeded on a vascular
prosthesis contribute to the restoration of a physiologic vascular
wall. J Vasc Surg. 47:1313–1321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hashi CK, Zhu Y, Yang GY, Young WL, Hsiao
BS, Wang K, Chu B and Li S: Antithrombogenic property of bone
marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc
Natl Acad Sci USA. 104:11915–11920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gimble JM, Guilak F and Bunnell BA:
Clinical and preclinical translation of cell-based therapies using
adipose tissue-derived cells. Stem Cell Res Ther. 1:192010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Ugarte DA, Morizono K, Elbarbary A,
Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim
P, et al: Comparison of multi-lineage cells from human adipose
tissue and bone marrow. Cells Tissues Organs. 174:101–109. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh
K, Bae YC and Jung JS: Characterization and expression analysis of
mesenchymal stem cells from human bone marrow and adipose tissue.
Cell Physiol Biochem. 14:311–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen
P, Ma K and Zhou C: Comparative analysis of mesenchymal stem cells
from bone marrow, cartilage, and adipose tissue. Stem Cells Dev.
17:761–773. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Khan D, Delling J and Tobiasch E:
Mechanisms underlying the osteo- and adipo-differentiation of human
mesenchymal stem cells. Sci World J. 793823:2012. View Article : Google Scholar
|
|
26
|
Mueller SM and Glowacki J: Age-related
decline in the osteogenic potential of human bone marrow cells
cultured in three-dimensional collagen sponges. J Cell Biochem.
82:583–590. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stenderup K, Justesen J, Clausen C and
Kassem M: Aging is associated with decreased maximal life span and
accelerated senescence of bone marrow stromal cells. Bone.
33:919–926. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim Y, Kim H, Cho H, Bae Y, Suh K and Jung
J: Direct comparison of human mesenchymal stem cells derived from
adipose tissues and bone marrow in mediating neovascularization in
response to vascular ischemia. Cell Physiol Biochem. 20:867–876.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
van Steenberghe M, Schubert T, Guiot Y,
Goebbels RM and Gianello P: Improvement of mesh recolonization in
abdominal wall reconstruction with adipose vs. bone marrow
mesenchymal stem cells in a rodent model. J Pediatr Surg.
52:1355–1362. 2017. View Article : Google Scholar
|
|
30
|
Rasmussen JG, Frøbert O, Holst-Hansen C,
Kastrup J, Baandrup U, Zachar V, Fink T and Simonsen U: Comparison
of human adipose-derived stem cells and bone marrow-derived stem
cells in a myocardial infarction model. Cell Transplant.
23:195–206. 2014. View Article : Google Scholar
|
|
31
|
Razavi S, Zarkesh-Esfahani H, Morshed M,
Vaezifar S, Karbasi S and Golozar MA: Nanobiocomposite of
poly(lactide-co-glycolide)/chitosan electrospun scaffold can
promote proliferation and transdifferentiation of Schwann-like
cells from human adipose-derived stem cells. J Biomed Mater Res A.
103:2628–2634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kuhl C, Tautenhahn R, Böttcher C, Larson
TR and Neumann S: CAMERA: An integrated strategy for compound
spectra extraction and annotation of liquid chromatography/mass
spectrometry data sets. Anal Chem. 84:283–289. 2012. View Article : Google Scholar
|
|
33
|
Trygg J, Holmes E and Lundstedt T:
Chemometrics in metabonomics. J Proteome Res. 6:469–479. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
van Velzen EJ, Westerhuis JA, van
Duynhoven JP, van Dorsten FA, Hoefsloot HC, Jacobs DM, Smit S,
Draijer R, Kroner CI and Smilde AK: Multilevel data analysis of a
crossover designed human nutritional intervention study. J Proteome
Res. 7:4483–4491. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fong MY, McDunn J and Kakar SS:
Identification of metabolites in the normal ovary and their
transformation in primary and metastatic ovarian cancer. PLoS One.
6:e199632011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ke C, Hou Y, Zhang H, Yang K, Wang J, Guo
B, Zhang F, Li H, Zhou X, Li Y, et al: Plasma Metabolic Profiles in
Women are Menopause Dependent. PLoS One. 10:e01417432015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang T, Wu X, Yin M, Fan L, Zhang H, Zhao
F, Zhang W, Ke C, Zhang G, Hou Y, et al: Discrimination between
malignant and benign ovarian tumors by plasma metabolomic profiling
using ultra performance liquid chromatography/mass spectrometry.
Clin Chim Acta. 413:861–868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wishart DS, Jewison T, Guo AC, Wilson M,
Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, et al: HMDB
3.0 - The Human Metabolome Database in 2013. Nucleic Acids Res.
41:D801–D807. 2013. View Article : Google Scholar
|
|
39
|
Kanehisa M, Goto S, Sato Y, Kawashima M,
Furumichi M and Tanabe M: Data, information, knowledge and
principle: Back to metabolism in KEGG. Nucleic Acids Res.
42:D199–D205. 2014. View Article : Google Scholar :
|
|
40
|
No authors listed. Randomised trial of
cholesterol lowering in 4444 patients with coronary heart disease:
The Scandinavian Simvastatin Survival Study (4S). Lancet.
344:1383–1389. 1994.PubMed/NCBI
|
|
41
|
Nordestgaard BG and Varbo A: Triglycerides
and cardiovascular disease. Lancet. 384:626–635. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rader DJ and Hovingh GK: HDL and
cardiovascular disease. Lancet. 384:618–625. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ridker PM: LDL cholesterol: Controversies
and future therapeutic directions. Lancet. 384:607–617. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Campbell B and Kreider RB: Conjugated
linoleic acids. Curr Sports Med Rep. 7:237–241. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Loscher CE, Draper E, Leavy O, Kelleher D,
Mills KH and Roche HM: Conjugated linoleic acid suppresses NF-kappa
B activation and IL-12 production in dendritic cells through
ERK-mediated IL-10 induction. J Immunol. 175:4990–4998. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kritchevsky D, Tepper SA, Wright S,
Czarnecki SK, Wilson TA and Nicolosi RJ: Conjugated linoleic acid
isomer effects in atherosclerosis: Growth and regression of
lesions. Lipids. 39:611–616. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Toomey S, Harhen B, Roche HM, Fitzgerald D
and Belton O: Profound resolution of early atherosclerosis with
conjugated linoleic acid. Atherosclerosis. 187:40–49. 2006.
View Article : Google Scholar
|
|
48
|
Hassan Eftekhari M, Aliasghari F,
Babaei-Beigi MA and Hasanzadeh J: Effect of conjugated linoleic
acid and omega-3 fatty acid supplementation on inflammatory and
oxidative stress markers in atherosclerotic patients. ARYA
Atheroscler. 9:311–318. 2013.
|
|
49
|
Dilzer A and Park Y: Implication of
conjugated linoleic acid (CLA) in human health. Crit Rev Food Sci
Nutr. 52:488–513. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
McCrorie TA, Keaveney EM, Wallace JM,
Binns N and Livingstone MB: Human health effects of conjugated
linoleic acid from milk and supplements. Nutr Res Rev. 24:206–227.
2011. View Article : Google Scholar
|
|
51
|
Onakpoya IJ, Posadzki PP, Watson LK,
Davies LA and Ernst E: The efficacy of long-term conjugated
linoleic acid (CLA) supplementation on body composition in
overweight and obese individuals: A systematic review and
meta-analysis of randomized clinical trials. Eur J Nutr.
51:127–134. 2012. View Article : Google Scholar
|
|
52
|
Risérus U, Berglund L and Vessby B:
Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in
obese middle-aged men with signs of the metabolic syndrome: a
randomised controlled trial. Int J Obes Relat Metab Disord.
25:1129–1135. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Churruca I, Fernández-Quintela A and
Portillo MP: Conjugated linoleic acid isomers: Differences in
metabolism and biological effects. Biofactors. 35:105–111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Abduljabbar R, Al-Kaabi MM, Negm OH,
Jerjees D, Muftah AA, Mukherjee A, Lai CF, Buluwela L, Ali S, Tighe
PJ, et al: Prognostic and biological significance of peroxisome
proliferator-activated receptor-gamma in luminal breast cancer.
Breast Cancer Res Treat. 150:511–522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Huang WC, Tu RS, Chen YL, Tsai YY, Lin CF
and Liou CJ: Conjugated linoleic acids suppress inflammatory
response and ICAM-1 expression through inhibition of NF-κB and MAPK
signaling in human bronchial epithelial cells. Food Funct.
7:2025–2033. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Smit LA, Baylin A and Campos H: Conjugated
linoleic acid in adipose tissue and risk of myocardial infarction.
Am J Clin Nutr. 92:34–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Moloney F, Yeow TP, Mullen A, Nolan JJ and
Roche HM: Conjugated linoleic acid supplementation, insulin
sensitivity, and lipoprotein metabolism in patients with type 2
diabetes mellitus. Am J Clin Nutr. 80:887–895. 2004.PubMed/NCBI
|
|
58
|
Eyjolfson V, Spriet LL and Dyck DJ:
Conjugated linoleic acid improves insulin sensitivity in young,
sedentary humans. Med Sci Sports Exerc. 36:814–820. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bassaganya-Riera J, Hontecillas R, Horne
WT, Sandridge M, Herfarth HH, Bloomfeld R and Isaacs KL: Conjugated
linoleic acid modulates immune responses in patients with mild to
moderately active Crohn's disease. Clin Nutr. 31:721–727. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Larsson SC, Bergkvist L and Wolk A:
High-fat dairy food and conjugated linoleic acid intakes in
relation to colorectal cancer incidence in the Swedish Mammography
Cohort. Am J Clin Nutr. 82:894–900. 2005.PubMed/NCBI
|
|
61
|
McCann SE, Ip C, Ip MM, McGuire MK, Muti
P, Edge SB, Trevisan M and Freudenheim JL: Dietary intake of
conjugated linoleic acids and risk of premenopausal and
postmenopausal breast cancer, Western New York Exposures and Breast
Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev.
13:1480–1484. 2004.PubMed/NCBI
|
|
62
|
Moon HS: Biological effects of conjugated
linoleic acid on obesity-related cancers. Chem Biol Interact.
224:189–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Louw L: Effects of conjugated linoleic
acid and high oleic acid safflower oil in the treatment of children
with HPV-induced laryngeal papillomatosis: A randomized,
double-blinded and crossover preliminary study. Lipids Health Dis.
11:1362012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu GY, Liu J, Wang YL, Liu Y, Shao Y, Han
Y, Qin YR, Xiao FJ, Li PF, Zhao LJ, et al: Adipose-derived
mesenchymal stem cells ameliorate lipid metabolic disturbance in
mice. Stem Cells Transl Med. 5:1162–1170. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Martins SV, Madeira A, Lopes PA, Pires VM,
Alfaia CM, Prates JA, Moura T and Soveral G: Adipocyte membrane
glycerol permeability is involved in the anti-adipogenic effect of
conjugated linoleic acid. Biochem Biophys Res Commun. 458:356–361.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ivanova-Todorova E, Bochev I, Mourdjeva M,
Dimitrov R, Bukarev D, Kyurkchiev S, Tivchev P, Altunkova I and
Kyurkchiev DS: Adipose tissue-derived mesenchymal stem cells are
more potent suppressors of dendritic cells differentiation compared
to bone marrow-derived mesenchymal stem cells. Immunol Lett.
126:37–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
